NASDAQ:EVGN • IL0011050551
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for EVOGENE LTD (EVGN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2025-05-22 | Lake Street | Maintains | Buy -> Buy |
| 2024-08-23 | Lake Street | Maintains | Buy -> Buy |
| 2023-10-02 | Alliance Global Partners | Initiate | Buy |
| 2023-08-18 | Lake Street | Maintains | Buy -> Buy |
| 2023-07-21 | Roth MKM | Maintains | Buy -> Buy |
| 2023-05-02 | Lake Street | Initiate | Buy |
| 2022-09-12 | Aegis Capital | Maintains | Buy |
| 2021-10-08 | Roth Capital | Initiate | Buy |
| 2021-07-29 | Aegis Capital | Initiate | Buy |
| 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | ||
|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 1.68M 80.65% | 5.64M 235.71% | 8.511M 50.90% | 3.993M -53.08% | 2.193M -45.08% | 3.723M 69.77% | |
| EBITDA YoY % growth | -27.74M 3.11% | -23.912M 13.80% | -19.161M 19.87% | -10.207M 46.73% | -6.911M 32.30% | -6.962M -0.74% | |
| EBIT YoY % growth | -30.32M 1.75% | -26.524M 12.52% | -21.665M 18.32% | -12.887M 40.52% | -10.991M 14.71% | -11.297M -2.78% | |
| Operating Margin | -1,804.76% | -470.28% | -254.55% | -322.73% | -501.16% | -303.42% | |
| EPS YoY % growth | -6.40 7.25% | -5.30 17.19% | -3.11 41.32% | -0.63 62.38% | -1.38 -17.69% | -1.02 25.93% |
All data in USD
| Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|
| EPS Q2Q % growth | -0.33 14.11% | -0.47 24.32% | -0.44 -199.68% | -0.26 58.20% |
| Revenue Q2Q % growth | 3.06M 25.20% | 510K -42.31% | 4.08M 1,207.69% | 6.12M 1,849.04% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | N/A | N/A | N/A | N/A |
All data in USD
7 analysts have analysed EVGN and the average price target is 2.55 USD. This implies a price increase of 242.14% is expected in the next year compared to the current price of 0.7453.
EVOGENE LTD (EVGN) will report earnings on 2026-05-19.
The consensus EPS estimate for the next earnings of EVOGENE LTD (EVGN) is -0.33 USD and the consensus revenue estimate is 3.06M USD.
The consensus rating for EVOGENE LTD (EVGN) is 82.8571 / 100 . This indicates that analysts generally have a positive outlook on the stock.